Capital Advisors Inc’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,523
| Closed | -$239K | – | 329 |
|
|
2024
Q1 | $239K | Sell |
2,523
-100
| -4% | -$9.49K | 0.01% | 273 |
|
|
2023
Q4 | $234K | Buy |
+2,623
| New | +$234K | 0.01% | 264 |
|
|
2023
Q3 | – | Sell |
-2,673
| Closed | -$222K | – | 284 |
|
|
2023
Q2 | $222K | Hold |
2,673
| – | – | 0.01% | 250 |
|
|
2023
Q1 | $204K | Buy |
+2,673
| New | +$204K | 0.01% | 244 |
|
|
2021
Q4 | – | Sell |
-140,846
| Closed | -$17.7M | – | 256 |
|
|
2021
Q3 | $17.7M | Buy |
140,846
+42,882
| +44% | +$5.39M | 0.53% | 75 |
|
|
2021
Q2 | $13.3M | Sell |
97,964
-72,512
| -43% | -$9.82M | 0.4% | 87 |
|
|
2021
Q1 | $23.1M | Sell |
170,476
-53,915
| -24% | -$7.31M | 0.76% | 54 |
|
|
2020
Q4 | $31.6M | Buy |
224,391
+12,265
| +6% | +$1.73M | 1.13% | 24 |
|
|
2020
Q3 | $23.6M | Buy |
212,126
+5,396
| +3% | +$601K | 0.96% | 35 |
|
|
2020
Q2 | $23.5M | Buy |
206,730
+13,345
| +7% | +$1.52M | 0.98% | 32 |
|
|
2020
Q1 | $15M | Buy |
193,385
+15,759
| +9% | +$1.22M | 0.81% | 44 |
|
|
2019
Q4 | $16.9M | Buy |
177,626
+24,763
| +16% | +$2.36M | 0.73% | 47 |
|
|
2019
Q3 | $13.4M | Hold |
152,863
| – | – | 0.66% | 45 |
|
|
2019
Q2 | $13.4M | Buy |
152,863
+83,754
| +121% | +$7.35M | 0.66% | 45 |
|
|
2019
Q1 | $6.26M | Buy |
69,109
+32,269
| +88% | +$2.92M | 0.67% | 22 |
|
|
2018
Q4 | $2.64M | Buy |
+36,840
| New | +$2.64M | 0.17% | 93 |
|